<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02821156</url>
  </required_header>
  <id_info>
    <org_study_id>ALMED-13-C4-046</org_study_id>
    <nct_id>NCT02821156</nct_id>
  </id_info>
  <brief_title>Study on the Use of Inhaled NO (iNO)</brief_title>
  <acronym>POSITIVE</acronym>
  <official_title>Prospective Observational Study on the Use of Inhaled NO (iNO) Administered Through an Integrated deliVEry and Monitoring Device EZ-KINOX</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Air Liquide Santé International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>EURAXI Pharma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Air Liquide Santé International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, observational, multicenter study conducted during 1 year in adult and
      paediatric intensive care units equipped with the EZ-KINOX™ system.

      A maximum of 250 patients (newborns to adults, suffering from Pulmonary Arterial Hypertension
      (PAH) associated with cardiac surgery or Persistent Pulmonary Hypertension in the Newborn
      (PPHN) receiving iNO through the integrated delivery and monitoring EZ-KINOX™ system was
      planned to be included.

      The study is strictly non-interventional with the aim of describing current practices and
      therefore did not affect the patient usual management.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is intended to describe daily practice and therefore, there is not a standardized
      protocol but only patient-based and site-based questionnaires.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>iNO characteristics of administration:doses, ventilation mode,concomitant pulmonary vasodilator treatments</measure>
    <time_frame>Through iNO administration, an average of 4 days</time_frame>
    <description>Data collected by questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Profile of patients: age, gender, disease characteristics.</measure>
    <time_frame>1 day</time_frame>
    <description>Data collected by questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and percentage of patients with adverse events</measure>
    <time_frame>During iNO administration, an average of 4 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and percentage of patients with adverse drug reaction</measure>
    <time_frame>From 1h after the end of iNO administration up to 28 days after ICU discharge</time_frame>
    <description>As no adverse drug reaction occured during this study, no specific data on time frame can be implemented</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigator's opinion regarding EZ-KINOX use</measure>
    <time_frame>Through iNO administration, an average of 4 days</time_frame>
    <description>Data collected by questionnaire</description>
  </secondary_outcome>
  <enrollment type="Actual">239</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with PAH associated with heart surgery or PPHN
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Newborn &gt; or = to 34 weeks gestational age suffering from hypoxic respiratory failure
             with pulmonary hypertension (France only) or patient presenting post-operative
             pulmonary hypertension associated with cardiac surgery (France and Belgium) · Patient
             treated with iNO delivered with EZ-KINOX™

        Exclusion Criteria:

          -  Newborn dependent on a right-to-left shunt or with a &quot;malignant&quot; left-right arterial
             canal

          -  Newborn with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe POUARD, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hôpital Necker-Enfants Malades</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cliniques Universitaires ST Luc</name>
      <address>
        <city>Bruxelles</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Sart TILMAN</name>
      <address>
        <city>Liège</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <state>Cedex 13</state>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Necker-Enfants Malades</name>
      <address>
        <city>Paris</city>
        <state>Paris cedex</state>
        <zip>75743</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Haut-Lévèque</name>
      <address>
        <city>Bordeaux</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital du Bocage Central</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Montpellier - Hôpital Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes - Hôpital Laennec</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Hôtel Dieu</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Trousseau</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Necker-Enfants Malades</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>American Memorial Hospital</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <zip>31076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 1991 Nov 9;338(8776):1173-4.</citation>
    <PMID>1682593</PMID>
  </results_reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 20, 2016</study_first_submitted>
  <study_first_submitted_qc>June 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2016</study_first_posted>
  <last_update_submitted>June 29, 2016</last_update_submitted>
  <last_update_submitted_qc>June 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

